Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

For Health Professionals

Emergency Medicine Research

The Department of Emergency Medicine practices an integrated approach of research and clinical care which creates a critical pathway to better patient care both in and out of the hospital. Our Mission is to foster a research environment which reflects our commitment to creating innovative, affordable systems of care, ultimately improving patient health and their healthcare experience.

Currently, the department is participating in over 60 different research projects, which include several multicenter clinical trials and investigator-initiated studies. The Department of Emergency Medicine routinely collaborates with iREACH, the Virtual Education and Simulation Technologies (VEST) Center, Trauma/Surgical Critical Care, Cardiology, Department of Medicine, and the Department of Family Medicine. We are also an active site for the research network Neurological Emergencies Treatment Trials (NETT).

Key areas of interest include:

  • EMS
  • Emergency Ultrasound
  • Sepsis
  • Stroke
  • Operational
  • Medical Student and Resident Education

Clinical Investigators

Under the leadership of Dr. John Powell Department of Emergency Medicine Chair, Dr. Jenna Fredette, Emergency Medicine Residency Program Director and Dr. Jason Nomura, Director of Emergency Medicine Research, our Academic Faculty serve as principal investigators and advisors to the residents while working on both departmental research and multi-center trials. Residents have the opportunity to participate in cutting edge science while being mentored by an experienced physician investigator. Our faculty and residents are often selected to present their completed research projects at national forums such as Society of Academic Emergency Medicine (SAEM) and American College of Emergency Physicians (ACEP).

Designated Academic Faculty:

  • Dr. Jeremy Berberian
  • Dr. Julie Cooper
  • Dr. Jenna Fredette
  • Dr. Leila Getto
  • Dr. Michael Hansen
  • Dr. Robert Hsu
  • Dr. Stephen Koczirka
  • Dr. Patrick Matthews
  • Dr. Jonathan McGhee
  • Dr. Jason Nomura
  • Dr. Amit Padaki
  • Dr. Brent Passarello
  • Dr. Justin Stowens
  • Dr. Gregory Wanner
  • Dr. Erin Watson
  • Dr. Eli Zeserson

Research efforts are supported by administrative staff and certified clinical research nurse coordinators. For more information, contact Barbara Debbage, RN, BSN, CCRC, Emergency Medicine Research Manager at 302-733-4198 or Barbara.j.debbage@christianacare.org.